IL6 and obesity disorder: A vast number of epidemiological, genetic, rodent, and human in vivo and in vitro studies have investigated the putative role of action/lack of action of IL-6 in the pathogeneses underlying obesity, insulin resistance, β-cell destruction, type 1 diabetes, and type 2 diabetes.